Learn More
Novus Biologicals™ TRAF-6 Inhibitor Peptide Set

Applications: In vitro assay, Block/Neutralize
Supplier: Novus Biologicals™ NBP226506
Specifications
Human, Mouse, Rat | |
TRAF6 Inhibitor peptide: 2 x 1mg (lyophilized) DRQIKIWFQNRRMKWKKRKIPTEDEY (TRAF6 binding sequence: RKIPTEDEY). Molecular weight: 3494. Antennapedia Control peptide: 2 x 1mg (lyophilized) DRQIKIWFQNRRMKWKK. Molecular weight: 2361. | |
Store at -20°C. Avoid freeze-thaw cycles. | |
TRAF-6 Inhibitor Peptide Set | |
TRAF-6 |
White | |
Inhibition of RANKL mediated osteoclast differentiation. Researchers can study the effect of TRAF6 inhibitor peptide using a variety of methods, such as EMSA, NF-kB/p65 ELISA,IkBa phosphorylation ELISA, osteoclast differentiation assay. The Osteoclast formation assay protocol is a guideline which may need to be optimized for different cell types. Use in In vitro assay and blocking neutralizing reported in scientific literature (PMID 24829345) | |
2 mg | |
3494 | |
Lyophilized Solid |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
For Research Use Only